MEGA GENOMICS (06667) released its interim results, with revenue reaching 192 million yuan, a significant year-on-year increase of 136.8%.
Meigen Gene (06667) announced its results for the six months ended June 30, 2026. The group achieved revenue of 192 million yuan, a year-on-year increase of 136.8%; gross profit of 63.678 million yuan, a year-on-year increase of 5.9%; and net profit of 24.751 million yuan, with earnings per share of 0.12 yuan.
MEGA GENOMICS (06667) announced its results for the six months ending June 30, 2026, reporting revenues of 192 million yuan, a year-on-year increase of 136.8%; gross profit of 63.678 million yuan, an increase of 5.9%; and a net profit of 24.751 million yuan, with earnings per share of 0.12 yuan.
The announcement stated that revenue saw significant growth during the reporting period, primarily due to the group's continued expansion of product categories, improvement of product matrix layout, and optimization of overall business structure. Multiple coordinated initiatives effectively drove a steady increase in overall revenue scale.
Related Articles
METASURFACE (08637) released its interim results, with a net profit attributable to shareholders of SGD 3.705 million, a decrease of 57.69% compared to the same period last year.
PLATEAU TL (08402) announces its interim results, reporting a net loss of approximately SGD 297,300, narrowing by 89.15% year-on-year.
JLOGO HLDGS (08527) announced its interim results, reporting a shareholder loss of SGD 1.045 million, an increase of 40.27% year-on-year.
METASURFACE (08637) released its interim results, with a net profit attributable to shareholders of SGD 3.705 million, a decrease of 57.69% compared to the same period last year.
PLATEAU TL (08402) announces its interim results, reporting a net loss of approximately SGD 297,300, narrowing by 89.15% year-on-year.
JLOGO HLDGS (08527) announced its interim results, reporting a shareholder loss of SGD 1.045 million, an increase of 40.27% year-on-year.
RECOMMEND
